Daniela E. Kirwan

1.1k total citations
26 papers, 489 citations indexed

About

Daniela E. Kirwan is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Daniela E. Kirwan has authored 26 papers receiving a total of 489 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 15 papers in Epidemiology and 5 papers in Surgery. Recurrent topics in Daniela E. Kirwan's work include Tuberculosis Research and Epidemiology (16 papers), Mycobacterium research and diagnosis (9 papers) and Pneumocystis jirovecii pneumonia detection and treatment (7 papers). Daniela E. Kirwan is often cited by papers focused on Tuberculosis Research and Epidemiology (16 papers), Mycobacterium research and diagnosis (9 papers) and Pneumocystis jirovecii pneumonia detection and treatment (7 papers). Daniela E. Kirwan collaborates with scholars based in United Kingdom, United States and Peru. Daniela E. Kirwan's co-authors include Robert H. Gilman, Jon S. Friedland, Judith White, J. Jones, Edwin Massey, Hamna J. Qureshi, Mirko Zimic, Stephen C. Robson, S. Allard and Patricia Sheen and has published in prestigious journals such as PLoS ONE, American Journal of Respiratory and Critical Care Medicine and Scientific Reports.

In The Last Decade

Daniela E. Kirwan

26 papers receiving 481 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniela E. Kirwan United Kingdom 12 294 198 98 93 81 26 489
Eliud Sepulveda United States 9 148 0.5× 197 1.0× 79 0.8× 76 0.8× 65 0.8× 10 801
Olumuyiwa Owolabi Gambia 15 342 1.2× 236 1.2× 90 0.9× 42 0.5× 68 0.8× 38 541
Constantina Politis Greece 17 156 0.5× 125 0.6× 51 0.5× 330 3.5× 23 0.3× 52 871
Mariana Araújo‐Pereira Brazil 13 213 0.7× 169 0.9× 81 0.8× 21 0.2× 80 1.0× 52 423
Bisma Rauff Pakistan 9 160 0.5× 319 1.6× 27 0.3× 56 0.6× 83 1.0× 21 670
Yuanhao Liang China 15 170 0.6× 123 0.6× 44 0.4× 16 0.2× 155 1.9× 48 545
G Gaeta Italy 12 95 0.3× 249 1.3× 110 1.1× 15 0.2× 67 0.8× 22 809
Martha Maria Oliveira Brazil 15 390 1.3× 300 1.5× 195 2.0× 44 0.5× 41 0.5× 37 546
Evelyn Lavu Papua New Guinea 12 174 0.6× 154 0.8× 61 0.6× 11 0.1× 147 1.8× 25 438
Celso Spada Brazil 16 174 0.6× 348 1.8× 20 0.2× 74 0.8× 39 0.5× 39 653

Countries citing papers authored by Daniela E. Kirwan

Since Specialization
Citations

This map shows the geographic impact of Daniela E. Kirwan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniela E. Kirwan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniela E. Kirwan more than expected).

Fields of papers citing papers by Daniela E. Kirwan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniela E. Kirwan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniela E. Kirwan. The network helps show where Daniela E. Kirwan may publish in the future.

Co-authorship network of co-authors of Daniela E. Kirwan

This figure shows the co-authorship network connecting the top 25 collaborators of Daniela E. Kirwan. A scholar is included among the top collaborators of Daniela E. Kirwan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniela E. Kirwan. Daniela E. Kirwan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gavidia, César M., et al.. (2023). Impaired spatial working memory and reduced hippocampal neuronal density in a rat model of neurocysticercosis. Frontiers in Cellular Neuroscience. 17. 1183322–1183322. 2 indexed citations
2.
Turner, Frances, Daniela E. Kirwan, Candice Roufosse, et al.. (2023). An acidic microenvironment in Tuberculosis increases extracellular matrix degradation by regulating macrophage inflammatory responses. PLoS Pathogens. 19(7). e1011495–e1011495. 5 indexed citations
3.
Shinkaruk, Svitlana, Robert H. Gilman, Daniela E. Kirwan, et al.. (2022). Biorecognition and detection of antigens from Mycobacterium tuberculosis using a sandwich ELISA associated with magnetic nanoparticles. Journal of Pharmaceutical and Biomedical Analysis. 215. 114749–114749. 7 indexed citations
4.
Owen, Sophie I., Emanuele Giorgi, David J. Clark, et al.. (2022). SARS-CoV-2 enzyme-linked immunosorbent assays as proxies for plaque reduction neutralisation tests. Scientific Reports. 12(1). 3351–3351. 2 indexed citations
5.
Santos, Victor Santana, Thomas Edwards, Emanuele Giorgi, et al.. (2021). Prevalence of neutralising antibodies against SARS-CoV-2 in acute infection and convalescence: A systematic review and meta-analysis. PLoS neglected tropical diseases. 15(7). e0009551–e0009551. 14 indexed citations
6.
Kirwan, Daniela E., et al.. (2021). Platelet Activation and the Immune Response to Tuberculosis. Frontiers in Immunology. 12. 631696–631696. 33 indexed citations
7.
Lopez, Juan M., Harry Saavedra, Daniela E. Kirwan, et al.. (2020). Mycobacterium tuberculosis ribosomal protein S1 (RpsA) and variants with truncated C-terminal end show absence of interaction with pyrazinoic acid. Scientific Reports. 10(1). 8356–8356. 15 indexed citations
8.
Gilman, Robert H., et al.. (2020). Immunological detection of pyrazine-2-carboxylic acid for the detection of pyrazinamide resistance in Mycobacterium tuberculosis. PLoS ONE. 15(11). e0241600–e0241600. 3 indexed citations
9.
Ugarte‐Gil, César, Rodrigo M. Carrillo‐Larco, & Daniela E. Kirwan. (2019). Latent tuberculosis infection and non-infectious co-morbidities: Diabetes mellitus type 2, chronic kidney disease and rheumatoid arthritis. International Journal of Infectious Diseases. 80. S29–S31. 13 indexed citations
10.
Kirwan, Daniela E., Alex Whittington, Nitya Krishnan, et al.. (2018). Platelets Regulate Pulmonary Inflammation and Tissue Destruction in Tuberculosis. American Journal of Respiratory and Critical Care Medicine. 198(2). 245–255. 48 indexed citations
11.
Bernabé‐Ortiz, Antonio, et al.. (2018). BIOIMPEDANCE MARKERS AND TUBERCULOSIS OUTCOME AMONG HIV-INFECTED PATIENTS. African Journal of Infectious Diseases. 12(2). 47–54. 4 indexed citations
12.
Paris, Luisa, Ruben Magni, Robyn P. Araujo, et al.. (2017). Urine lipoarabinomannan glycan in HIV-negative patients with pulmonary tuberculosis correlates with disease severity. Science Translational Medicine. 9(420). 80 indexed citations
13.
Bravard, Marjory A., Brian Tracey, José W. López, et al.. (2016). Protocol for studying cough frequency in people with pulmonary tuberculosis. BMJ Open. 6(4). e010365–e010365. 17 indexed citations
14.
Dudley, Matthew Z., Patricia Sheen, Robert H. Gilman, et al.. (2016). Detecting Mutations in the Mycobacterium tuberculosis Pyrazinamidase Gene pncA to Improve Infection Control and Decrease Drug Resistance Rates in Human Immunodeficiency Virus Coinfection. American Journal of Tropical Medicine and Hygiene. 95(6). 1239–1246. 5 indexed citations
15.
Aguirre, Luis A., et al.. (2014). Congenital Transmission of Multidrug-Resistant Tuberculosis. American Journal of Tropical Medicine and Hygiene. 91(1). 92–95. 9 indexed citations
16.
Qureshi, Hamna J., Edwin Massey, Daniela E. Kirwan, et al.. (2014). BCSH guideline for the use of anti‐D immunoglobulin for the prevention of haemolytic disease of the fetus and newborn. Transfusion Medicine. 24(1). 8–20. 108 indexed citations
17.
Kirwan, Daniela E., María Kathia Cárdenas, & Robert H. Gilman. (2012). Rapid Implementation of New TB Diagnostic Tests: Is It Too Soon for a Global Roll-Out of Xpert MTB/RIF?. American Journal of Tropical Medicine and Hygiene. 87(2). 197–201. 21 indexed citations
18.
Zimic, Mirko, Robert H. Gilman, Andrés H. Gutiérrez, et al.. (2012). A New Approach for Pyrazinamide Susceptibility Testing in Mycobacterium tuberculosis. Microbial Drug Resistance. 18(4). 372–375. 15 indexed citations
19.
Zimic, Mirko, Patricia Fuentes, Robert H. Gilman, et al.. (2011). Pyrazinoic acid efflux rate in Mycobacterium tuberculosis is a better proxy of pyrazinamide resistance. Tuberculosis. 92(1). 84–91. 33 indexed citations
20.
Kirwan, Daniela E.. (2009). Global health: current issues, future trends and foreign policy. Clinical Medicine. 9(3). 247–253. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eliud Sepulveda Breakdown of academic impact, for papers by Olumuyiwa Owolabi Breakdown of academic impact, for papers by Constantina Politis Breakdown of academic impact, for papers by Mariana Araújo‐Pereira Breakdown of academic impact, for papers by Bisma Rauff Breakdown of academic impact, for papers by Yuanhao Liang Breakdown of academic impact, for papers by G Gaeta Breakdown of academic impact, for papers by Martha Maria Oliveira Breakdown of academic impact, for papers by Evelyn Lavu Breakdown of academic impact, for papers by Celso Spada
Rankless by CCL
2026